Related Experiment Video

Updated: Aug 31, 2025

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

7.5K

The Role of Protein Kinase CK2 in Development and Disease Progression: A Critical Review

Daniel Halloran1, Venu Pandit1, Anja Nohe1

  • 1Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA.

Journal of Developmental Biology
|August 23, 2022
PubMed

Insights

Protein kinase CK2 (CK2) is vital for development and adult health, regulating key cellular processes. Inhibiting CK2 shows promise for treating cancers and bone disorders.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Protein kinase CK2 (CK2) is a crucial enzyme involved in numerous developmental and adult cellular processes.
  • Its functions are conserved across evolution, highlighting its fundamental importance.
  • Dysregulation of CK2 is linked to embryonic lethality, cancer, and neurological disorders.

Purpose of the Study:

  • To review the role of CK2 in development and adult homeostasis.
  • To summarize CK2 structure, targets, and signaling pathways.
  • To discuss CK2's implication in disease and emerging therapeutic strategies.

Main Methods:

  • Literature review of CK2's function, structure, and disease relevance.
  • Analysis of current research on CK2 inhibitors and their therapeutic potential.
  • Synthesis of information on CK2's role in development and disease progression.

Main Results:

  • CK2 is essential for neurogenesis, cardiogenesis, skeletogenesis, and spermatogenesis.
  • In adulthood, CK2 regulates osteogenesis, adipogenesis, chondrogenesis, neuron differentiation, and immune responses.
  • CK2 inhibitors like CX-4945 and CIBG-300 are in clinical trials for cancer and other diseases.

Conclusions:

  • CK2 is a critical regulator with widespread implications in health and disease.
  • Targeting CK2 offers a promising therapeutic avenue for various conditions, including cancer and bone disorders.
  • Further research into CK2 pathways and inhibitors is essential for developing effective treatments.
Keywords:
CIBG-300CX-4945cancercasein kinase IIdevelopment

More Related Videos

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

8.8K
Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

18.8K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.9K